Proof of concept clinical trial of M-281

Trial Profile

Proof of concept clinical trial of M-281

Phase of Trial: Phase II

Latest Information Update: 09 Jan 2018

At a glance

  • Drugs M 281 (Primary)
  • Indications Autoimmune disorders
  • Focus Proof of concept; Therapeutic Use
  • Most Recent Events

    • 09 Jan 2018 New trial record
    • 05 Jan 2018 According to a Momenta Pharmaceuticals medis release, this trial is expected to initiate in the second half of 2018.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top